Effect of Hyperuricaemia on Chronic Renal Disease

NCT03425708 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Hyperuricemia
Chronic Renal Disease

Interventions

DRUG: 20mg Febuxostat
DRUG: 40mg Febuxostat

Sponsor

The Affiliated Hospital of Xuzhou Medical University

Collaborators

[object Object]